Last reviewed · How we verify
NCT03141502: SSDRCT
The New Skin Stretching Device for Treatment of Limb Tension Wounds
Phase 4 trial testing Skin stretching device (SSD) in Trauma in 100 participants. Status unknown.
31 August 2018
Quick facts
| Lead sponsor | The First Affiliated Hospital of Dalian Medical University |
|---|---|
| Phase | Phase 4 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 11 May 2017 |
| Primary completion | 31 August 2018 |
| Estimated completion | 31 October 2018 |
| Sites | 1 location across China |
Drugs / interventions tested
- Skin stretching device (SSD)
- Skin grafting
Conditions studied
- Trauma — all drugs for Trauma →
- Fractures, Open — all drugs for Fractures, Open →
- Wounds and Injuries — all drugs for Wounds and Injuries →
- Skin Expander — all drugs for Skin Expander →
Sponsor
The First Affiliated Hospital of Dalian Medical University
Who can join
18 and older, any sex, with Trauma or Fractures, Open. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A randomized controlled trial is performed to evaluate the effectiveness and safety of the Skin Stretching Device (SSD) on limb tension incision closure by comparing whether the differences in wounds area, wounds closure time and scar assessment between the SSD and the skin grafting are statistically significant.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03141502
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Trauma
Currently open trials in the same condition.
- NCT07290634 — Comparative Outcomes of PCC and Recombinant Activated Factor VIIa in Trauma-Associated Massive Transfusion · recruiting
- NCT07485231 — Nitric Oxide (NO) and Endothelial Dysfunction in Women With PTSD · NA · recruiting
- NCT07473336 — The Effectiveness of RAPID-Based Psychological First Aid Training · NA · active not recruiting
- NCT07278505 — Study of Cannabidiol and Neuroimaging on Stress · Phase 1, PHASE2 · recruiting
- NCT02880163 — REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam · NA · recruiting
Other The First Affiliated Hospital of Dalian Medical University trials
Trials by the same sponsor.
- NCT07397390 — an Observational Study Evaluting the Effectiveness and Safety of DKutting LL Noval Scoring Balloon Angioplasty for Vesse · enrolling by invitation
- NCT06836999 — Deep Sedation in Catheter Ablation of Atrial Fibrillation · NA · not yet recruiting
- NCT06356701 — Tumor Nutritional Therapy in the First-line Treatment of Stage IV NSCLC · Phase 1 · unknown
- NCT06250842 — Benzodiazepine Impact on Cognitive Function: fNIRs and PET/MRI Study · recruiting
- NCT06056973 — Jinghua Weikang Capsule in the Treatment of Reflux Esophagitis · Phase 4 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03141502 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The First Affiliated Hospital of Dalian Medical University
- Last refreshed: 5 May 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03141502.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing